Innovation
18 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 424 times.
| Year | Filings |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 2.2K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include MEDIPAL, UTokyo Innovation Platform, Medical Incubator Japan, Keio Innovation Initiative.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 50% |
| Other / undisclosed | 10 | 50% |
Recent activity
12 Jun 2026
Milestone
regulatory
8 Jun 2026
Event
10th Cardiovascular Bioengineering (CVBE) Symposium 2026
24 Apr 2026
Partnership
Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)